Track topics on Twitter Track topics that are important to you
Beiersdorf Aktiengesellschaft / Key word(s): Mergers & Acquisitions
Beiersdorf acquires Coppertone from Bayer
Today Beiersdorf Aktiengesellschaft, Hamburg, entered into a definitive agreement with Bayer Aktiengesellschaft, Leverkusen, for the purchase of Bayer's sun care business marketed under the Coppertone brand for a purchase price of USD 550 million.
Through the acquisition of Coppertone, Beiersdorf is entering the world's largest sun care market, the USA, and strengthening its presence in North America. In 2018, the Coppertone business generated sales of around USD 213 million.
The completion of the transaction is subject to the approval of merger control authorities as well as further customary closing conditions, and is expected to take place in the third quarter 2019. The Supervisory Boards of both companies have already approved the transaction.
Dr. Jens Geißler
Head of Investor Relations
Tel.: +49 (40) 4909 5000
Fax: +49 (40) 4909 18 5000
Vice President Corporate Communications
Tel.: +49 (40) 4909 2001
Fax: +49 (40) 4909 2516
|Phone:||+49 (0)40 4909-0|
|Fax:||+49 (0)40 4909-34 34|
|Listed:||Regulated Market in Frankfurt (Prime Standard), Hamburg; Regulated Unofficial Market in Berlin, Dusseldorf, Hanover, Munich, Stuttgart, Tradegate Exchange|
|EQS News ID:||810653|
|End of Announcement||DGAP News Service|
Original Article: Beiersdorf Aktiengesellschaft: Beiersdorf acquires Coppertone from BayerNEXT ARTICLE
Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...